These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 16186388)

  • 41. Changes in (markers of) bone metabolism during high dose corticosteroid pulse treatment in patients with rheumatoid arthritis.
    Lems WF; Gerrits MI; Jacobs JW; van Vugt RM; van Rijn HJ; Bijlsma JW
    Ann Rheum Dis; 1996 May; 55(5):288-93. PubMed ID: 8660101
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Insulin-like growth factor I is required for the anabolic actions of parathyroid hormone on mouse bone.
    Bikle DD; Sakata T; Leary C; Elalieh H; Ginzinger D; Rosen CJ; Beamer W; Majumdar S; Halloran BP
    J Bone Miner Res; 2002 Sep; 17(9):1570-8. PubMed ID: 12211426
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Osteoblast-Specific Overexpression of Human WNT16 Increases Both Cortical and Trabecular Bone Mass and Structure in Mice.
    Alam I; Alkhouli M; Gerard-O'Riley RL; Wright WB; Acton D; Gray AK; Patel B; Reilly AM; Lim KE; Robling AG; Econs MJ
    Endocrinology; 2016 Feb; 157(2):722-36. PubMed ID: 26584014
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Periosteum-Induced Bone Formation by Distraction Osteogenesis: Histologic and Microcomputed Tomography Analysis.
    Nakahara K; Haga-Tsujimura M; Iizuka T; Saulacic N
    Int J Oral Maxillofac Implants; 2016; 31(4):785-92. PubMed ID: 27447143
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Restoration of bone mass in the severely osteopenic senescent rat.
    Sibonga JD; Zhang M; Ritman EL; Turner RT
    J Gerontol A Biol Sci Med Sci; 2000 Feb; 55(2):B71-8; discussion B79-84. PubMed ID: 10737682
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Flt-1 tyrosine kinase-deficient homozygous mice result in decreased trabecular bone volume with reduced osteogenic potential.
    Otomo H; Sakai A; Uchida S; Tanaka S; Watanuki M; Moriwaki S; Niida S; Nakamura T
    Bone; 2007 Jun; 40(6):1494-501. PubMed ID: 17379594
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Low serum levels of intact osteocalcin in patients with congestive heart failure.
    Schleithoff SS; Zittermann A; Stüttgen B; Tenderich G; Berthold HK; Körfer R; Stehle P
    J Bone Miner Metab; 2003; 21(4):247-52. PubMed ID: 12811631
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effects of collagen membrane application and cortical bone perforation on de novo bone formation in periosteal distraction: an experimental study in a rabbit calvaria.
    Nakahara K; Haga-Tsujimura M; Sawada K; Mottini M; Schaller B; Saulacic N
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2017 Feb; 123(2):173-182. PubMed ID: 27876575
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Normal bone density obtained in the absence of insulin receptor expression in bone.
    Irwin R; Lin HV; Motyl KJ; McCabe LR
    Endocrinology; 2006 Dec; 147(12):5760-7. PubMed ID: 16973725
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effect of cyclosporin A on bone mineral metabolism in experimental diabetes mellitus in the rat.
    Epstein S; Takizawa M; Stein B; Katz IA; Joffe II; Romero DF; Liang XG; Li M; Ke HZ; Jee WS
    J Bone Miner Res; 1994 Apr; 9(4):557-66. PubMed ID: 8030444
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Insulin receptor substrate-1 time-dependently regulates bone formation by controlling collagen Iα2 expression via miR-342.
    Guo Y; Tang CY; Man XF; Tang HN; Tang J; Wang F; Zhou CL; Tan SW; Feng YZ; Zhou HD
    FASEB J; 2016 Dec; 30(12):4214-4226. PubMed ID: 27623927
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effect of insulin treatment on osteocalcin levels in diabetic children and adolescents.
    Guarneri MP; Weber G; Gallia P; Chiumello G
    J Endocrinol Invest; 1993; 16(7):505-9. PubMed ID: 8227979
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Young overweight and obese women with lower circulating osteocalcin concentrations exhibit higher insulin resistance and concentrations of C-reactive protein.
    Lucey AJ; Paschos GK; Thorsdottir I; Martínéz JA; Cashman KD; Kiely M
    Nutr Res; 2013 Jan; 33(1):67-75. PubMed ID: 23351412
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Evaluation of modal damping factor as a diagnostic tool for osteoporosis and its relation with serum osteocalcin and collagen I N-telopeptide for monitoring the efficacy of alendronate in ovariectomized rats.
    Christopoulou GE; Stavropoulou A; Anastassopoulos G; Panteliou SD; Papadaki E; Karamanos NK; Panagiotopoulos E
    J Pharm Biomed Anal; 2006 Jun; 41(3):891-7. PubMed ID: 16488571
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Characterizing the BMP pathway in a wild type mouse model of distraction osteogenesis.
    Haque T; Hamade F; Alam N; Kotsiopriftis M; Lauzier D; St-Arnaud R; Hamdy RC
    Bone; 2008 Jun; 42(6):1144-53. PubMed ID: 18372226
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Monitoring of bone formation during distraction osteogenesis via osteocalcin: a time sequence study in dogs.
    Fink B; Fox F; Singer J; Skripitz R; Feldkamp J
    J Orthop Sci; 2002; 7(5):557-61. PubMed ID: 12355130
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Zoledronic acid prevents osteopenia and increases bone strength in a rabbit model of distraction osteogenesis.
    Little DG; Smith NC; Williams PR; Briody JN; Bilston LE; Smith EJ; Gardiner EM; Cowell CT
    J Bone Miner Res; 2003 Jul; 18(7):1300-7. PubMed ID: 12854841
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Diminished bone formation during diabetic fracture healing is related to the premature resorption of cartilage associated with increased osteoclast activity.
    Kayal RA; Tsatsas D; Bauer MA; Allen B; Al-Sebaei MO; Kakar S; Leone CW; Morgan EF; Gerstenfeld LC; Einhorn TA; Graves DT
    J Bone Miner Res; 2007 Apr; 22(4):560-8. PubMed ID: 17243865
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Short-term effects of growth hormone and insulin-like growth factor I on cancellous bone in rhesus macaque monkeys.
    Sass DA; Jerome CP; Bowman AR; Bennett-Cain A; Ginn TA; LeRoith D; Epstein S
    J Clin Endocrinol Metab; 1997 Apr; 82(4):1202-9. PubMed ID: 9100597
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Evaluation of the antiosteoporotic potential of Cimicifuga heracleifolia in female mice.
    Ahn BS; Yang M; Jang H; Lee HJ; Moon C; Kim JC; Jung U; Jo SK; Jang JS; Kim SH
    Phytother Res; 2012 May; 26(5):663-8. PubMed ID: 21987388
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.